vs
Side-by-side financial comparison of Koppers Holdings Inc. (KOP) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $432.7M, roughly 1.1× Koppers Holdings Inc.). Koppers Holdings Inc. runs the higher net margin — 6.9% vs 6.8%, a 0.0% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -9.3%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -6.7%).
Koppers is a global chemical and materials company based in Pittsburgh, Pennsylvania, United States. Its headquarters is an art-deco 1920s skyscraper, the Koppers Tower.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
KOP vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $432.7M | $493.8M |
| Net Profit | $29.7M | $33.7M |
| Gross Margin | 25.6% | — |
| Operating Margin | 11.5% | 9.9% |
| Net Margin | 6.9% | 6.8% |
| Revenue YoY | -9.3% | -1.7% |
| Net Profit YoY | 391.2% | 10.5% |
| EPS (diluted) | $1.44 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $432.7M | $493.8M | ||
| Q3 25 | $485.3M | $492.9M | ||
| Q2 25 | $504.8M | $468.8M | ||
| Q1 25 | $456.5M | $458.4M | ||
| Q4 24 | $477.0M | $502.4M | ||
| Q3 24 | $554.3M | $511.2M | ||
| Q2 24 | $563.2M | $504.3M | ||
| Q1 24 | $497.6M | $495.1M |
| Q4 25 | $29.7M | $33.7M | ||
| Q3 25 | $23.8M | $71.7M | ||
| Q2 25 | $16.4M | $39.3M | ||
| Q1 25 | $-13.9M | $20.7M | ||
| Q4 24 | $-10.2M | $30.5M | ||
| Q3 24 | $22.8M | $19.4M | ||
| Q2 24 | $26.8M | $-153.0M | ||
| Q1 24 | $13.0M | $4.0M |
| Q4 25 | 25.6% | — | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 22.6% | — | ||
| Q1 25 | 23.2% | — | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | 21.9% | — | ||
| Q2 24 | 21.6% | — | ||
| Q1 24 | 19.3% | — |
| Q4 25 | 11.5% | 9.9% | ||
| Q3 25 | 10.7% | 13.8% | ||
| Q2 25 | 7.7% | 12.8% | ||
| Q1 25 | 5.9% | 7.0% | ||
| Q4 24 | 1.3% | 7.8% | ||
| Q3 24 | 9.0% | 6.6% | ||
| Q2 24 | 10.2% | -31.3% | ||
| Q1 24 | 7.0% | 3.2% |
| Q4 25 | 6.9% | 6.8% | ||
| Q3 25 | 4.9% | 14.5% | ||
| Q2 25 | 3.2% | 8.4% | ||
| Q1 25 | -3.0% | 4.5% | ||
| Q4 24 | -2.1% | 6.1% | ||
| Q3 24 | 4.1% | 3.8% | ||
| Q2 24 | 4.8% | -30.3% | ||
| Q1 24 | 2.6% | 0.8% |
| Q4 25 | $1.44 | $0.40 | ||
| Q3 25 | $1.17 | $0.84 | ||
| Q2 25 | $0.81 | $0.46 | ||
| Q1 25 | $-0.68 | $0.24 | ||
| Q4 24 | $-0.47 | $0.37 | ||
| Q3 24 | $1.09 | $0.23 | ||
| Q2 24 | $1.25 | $-1.84 | ||
| Q1 24 | $0.59 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $375.2M |
| Total DebtLower is stronger | $928.3M | $570.5M |
| Stockholders' EquityBook value | $574.0M | $865.9M |
| Total Assets | $1.9B | $2.2B |
| Debt / EquityLower = less leverage | 1.62× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $8.0M |
| Q4 25 | $928.3M | $570.5M | ||
| Q3 25 | $932.9M | $577.2M | ||
| Q2 25 | $977.5M | $583.9M | ||
| Q1 25 | $989.0M | $590.5M | ||
| Q4 24 | $939.5M | $597.1M | ||
| Q3 24 | $989.4M | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $877.6M | — |
| Q4 25 | $574.0M | $865.9M | ||
| Q3 25 | $545.6M | $890.7M | ||
| Q2 25 | $526.8M | $833.8M | ||
| Q1 25 | $498.0M | $789.2M | ||
| Q4 24 | $488.7M | $764.9M | ||
| Q3 24 | $532.3M | $732.5M | ||
| Q2 24 | $509.2M | $706.5M | ||
| Q1 24 | $505.8M | $856.2M |
| Q4 25 | $1.9B | $2.2B | ||
| Q3 25 | $1.9B | $2.2B | ||
| Q2 25 | $1.9B | $2.1B | ||
| Q1 25 | $1.9B | $2.0B | ||
| Q4 24 | $1.9B | $2.2B | ||
| Q3 24 | $2.0B | $2.1B | ||
| Q2 24 | $1.9B | $2.0B | ||
| Q1 24 | $1.8B | $2.2B |
| Q4 25 | 1.62× | 0.66× | ||
| Q3 25 | 1.71× | 0.65× | ||
| Q2 25 | 1.86× | 0.70× | ||
| Q1 25 | 1.99× | 0.75× | ||
| Q4 24 | 1.92× | 0.78× | ||
| Q3 24 | 1.86× | — | ||
| Q2 24 | 1.97× | — | ||
| Q1 24 | 1.74× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.1M | $114.1M |
| Free Cash FlowOCF − Capex | $28.5M | — |
| FCF MarginFCF / Revenue | 6.6% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | 1.52× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $67.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | $114.1M | ||
| Q3 25 | $49.6M | $137.3M | ||
| Q2 25 | $50.5M | $137.2M | ||
| Q1 25 | $-22.7M | $-117.5M | ||
| Q4 24 | $74.7M | $133.0M | ||
| Q3 24 | $29.8M | $91.8M | ||
| Q2 24 | $27.2M | $107.0M | ||
| Q1 24 | $-12.3M | $-125.2M |
| Q4 25 | $28.5M | — | ||
| Q3 25 | $37.6M | — | ||
| Q2 25 | $38.4M | — | ||
| Q1 25 | $-37.0M | — | ||
| Q4 24 | $56.1M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $-38.6M | — |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 7.6% | — | ||
| Q1 25 | -8.1% | — | ||
| Q4 24 | 11.8% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | -7.8% | — |
| Q4 25 | 3.8% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | 1.52× | 3.39× | ||
| Q3 25 | 2.08× | 1.91× | ||
| Q2 25 | 3.08× | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 1.31× | 4.72× | ||
| Q2 24 | 1.01× | — | ||
| Q1 24 | -0.95× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KOP
| Other | $127.8M | 30% |
| Railroad Treated Products | $119.0M | 28% |
| Utility Poles | $79.8M | 18% |
| Pitch And Related Products | $74.1M | 17% |
| Carbon Black Feedstock And Distillates | $14.4M | 3% |
| Railroad Infrastructure Products And Services | $9.9M | 2% |
| Phthalic Anhydride Naphthalene And Other Chemicals | $7.7M | 2% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
